Timing of Antiviral Treatment Initiation is Critical to Reduce SARS‐CoV‐2 Viral Load-Reference-Cited by-同舟云学术

Timing of Antiviral Treatment Initiation is Critical to Reduce SARS‐CoV‐2 Viral Load

Published:2020-08-07 Issue:9 Volume:9 Page:509-514
ISSN:2163-8306
Container-title:CPT: Pharmacometrics & Systems Pharmacology
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Gonçalves Antonio¹,Bertrand Julie¹,Ke Ruian²,Comets Emmanuelle¹,Lamballerie Xavier³,Malvy Denis⁴⁵,Pizzorno Andrés⁶,Terrier Olivier⁶,Rosa Calatrava Manuel⁶,Mentré France¹,Smith Patrick⁷,Perelson Alan S.²,Guedj Jérémie¹

Affiliation:

1. Université de ParisIAMEINSERM Paris France

2. Theoretical Biology and Biophysics Los Alamos National Laboratory Los Alamos New Mexico USA

3. Institut Hospitalo‐Universitaire Méditerranée Infection UMR "Emergence des Pathologies Virales" (EPV: Aix‐Marseille University ‐ IRD 190 ‐ Inserm 1207 ‐ EHESP) Marseille France

4. Inserm UMR 1219 Université de Bordeaux Bordeaux France

5. Centre Hospitalier Universitaire de Bordeaux Bordeaux France

6. CIRI Centre International de Recherche en Infectiologie, (Team VirPath) Univ Lyon, Inserm, U1111 Université Claude Bernard Lyon 1CNRSUMR5308ENS de Lyon Lyon France

7. Certara Integrated Drug Development Princeton New Jersey USA

Funder

Roche

Agence Nationale de la Recherche

U.S. Department of Energy

Publisher

Wiley

Subject

Pharmacology (medical),Modeling and Simulation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/psp4.12543

Reference33 articles.